本公司及监事会全体成员保证公告内容真实、准确和完整，并对公告中 的虚假记载、误导性陈述或者重大遗漏承担责任。 海南海峡航运股份有限公司（以下简称"公司"或"海峡股份"）于 2025 年 9 月 3 日以 OA、电子邮件的形式向全体监事发出第八届监事会第十一次临时 会议通知及相关议案等材料。会议于 2025 年 9 月 9 日上午以通讯表决方式召开， 会议由公司监事会主席李燕女士召集并主持，应参加会议监事 5 人，实际参加会 议监事 5 人，会议召集、召开程序符合《公司法》、海峡股份《公司章程》的相 关规定。 与会监事认真审议了本次会议的议案，以记名投票表决的方式通过了如下决 议： 一、会议以 5 票赞成，0 票反对，0 票弃权，审议通过了关于购买 2 艘平板 货船的议案。同意公司下属的琼州海峡（海南）轮渡运输有限公司及其子公司琼 州海峡（广东）轮渡运输有限公司分别投资购买 1 艘平板货船并进行改造，单船 投资额不超过 7450 万元/艘，包含购买及改造费用等。该议案将提交股东会审议。 特此公告。 海南海峡航运股份有限公司 股票简称：海峡股份 股票代码：002320 公告编号：2025-69 海南海峡航运股份有 ...

股票简称：海峡股份 股票代码：002320 公告编号： 2025-68 海南海峡航运股份有限公司 第八届董事会第十四次临时会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中 的虚假记载、误导性陈述或者重大遗漏承担责任。 海南海峡航运股份有限公司（以下简称"公司"或"海峡股份"）于 2025 年 9 月 3 日以 OA、电子邮件的形式向全体董事发出第八届董事会第十四次临时 会议通知及相关议案等材料。会议于 2025 年 9 月 9 日以通讯表决方式举行，本 次会议由董事长王然先生主持，会议应出席董事 11 名，实际出席董事 11 名，会 议的召集、召开程序符合《公司法》和海峡股份《公司章程》的有关规定。与会 董事经充分审议，表决通过了以下决议： 一、会议以 11 票同意，0 票反对，0 票弃权，审议通过了关于购买 2 艘平板 货船的议案。 （三）项目经济性评价 经测算，由于海南与广东地区企业所得税率不同，项目预期收益略有不同， 轮渡公司购买 1 艘平板货船项目内部收益率（税后）为 8.55%，静态投资回收期 （运营期起）为 10.2 年。轮渡子公司购买 1 艘平板货船项目内部收益率（税 ...

Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]

Core Viewpoint - The company is focusing on enhancing ship operational efficiency and optimizing the age structure of its fleet while exploring the application of new energy vessels in its routes, pending thorough assessments of safety, economic viability, and feasibility [2]. Group 1 - The company is updating its shipping capacity primarily to improve operational efficiency [2]. - The company is optimizing the age structure of its vessels [2]. - The company is researching the application of new energy vessels, which will be implemented only after comprehensive evaluations [2].

Group 1 - The company announced the approval of two significant resolutions during the 10th temporary meeting of the 8th Supervisory Board, including the cancellation of the Supervisory Board and the purchase of liability insurance for directors and senior management [2]

Core Viewpoint - The company, Haixia Co., announced the approval of multiple proposals during the 13th temporary meeting of its 8th Board of Directors held on the evening of September 2 [2] Group 1 - The company held a temporary board meeting to discuss and approve various proposals [2]

Core Viewpoint - The company, Haixia Co., announced that it will hold its sixth extraordinary general meeting of shareholders on September 18, 2025, to review multiple proposals, including the motion to abolish the supervisory board [2] Group 1 - The extraordinary general meeting is scheduled for September 18, 2025 [2] - The agenda includes the proposal to cancel the supervisory board [2]

股票简称：海峡股份 股票代码：002320 公告编号：2025-67 海南海峡航运股份有限公司 关于召开 2025 年第六次临时股东会的通知 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中 的虚假记载、误导性陈述或者重大遗漏承担责任。 一、召开会议基本情况 （一）股东会届次：2025 年第六次临时股东会 （二）股东会召集人：公司董事会。2025 年 9 月 2 日，海南海峡航运股份 有限公司（以下简称"公司"或"海峡股份"）召开第八届董事会第十三次临时 会议，以 11 票赞同、0 票反对、0 票弃权，审议通过了《关于召开 2025 年第六 次临时股东会的议案》，董事会决定于 2025 年 9 月 18 日（星期四）召开 2025 年第六次临时股东会。 （三）会议召开的合法、合规性：公司第八届董事会第十二次会议决议召开 2025 年第六次临时股东会。本次股东会的召开符合有关法律、行政法规、部门 规章、规范性文件、深交所业务规则和海峡股份《公司章程》等规定。 （四）会议召开的日期、时间： 现场会议时间：2025 年 9 月 18 日下午 15:00 网络投票时间：通过深圳证券交易所交易系统进行网络 ...

Core Points - The company held its 13th temporary board meeting on September 2, 2025, where several resolutions were passed regarding amendments to its internal regulations and governance structure [1][2][3]. Group 1: Amendments to Company Regulations - The board approved the revision of the Articles of Association, which includes the adjustment of the supervisory board's powers to be exercised by the audit committee of the board [2][4]. - The board also approved the revision of the Shareholders' Meeting Rules, which involves the cancellation of the supervisory board and adjustments to the powers of the shareholders' meeting [4][5]. - The board passed a resolution to amend the Board Meeting Rules, optimizing the board's powers, meeting procedures, and independent director responsibilities [6][7]. - The board approved the revision of the Special Committee Meeting Rules, detailing the composition, responsibilities, and procedures of the special committees [7][8]. - The board agreed to amend the Profit Distribution Management Rules, which includes conditions for cash dividends and mechanisms for minority shareholder participation [10][11]. - The board approved the revision of the Major Information Internal Reporting Rules, updating terminology and reporting procedures [12]. - The board passed amendments to the Independent Director Work Rules, which cover independence standards and work mechanisms [13][14]. - The board approved the revision of the Secretary of the Board Work Rules, detailing qualifications and responsibilities [15]. - The board also amended the General Manager Work Rules, adjusting supervisory subjects and qualifications [16][17]. Group 2: Management Changes - The board approved the appointment of Wu Linze as the new Vice General Manager, following the retirement of Zhang Ting [18][26]. - Zhang Ting will continue to serve as the Vice Chairman and Director after her resignation from the Vice General Manager position [27][28]. Group 3: Upcoming Shareholder Meeting - The company has scheduled the 2025 Sixth Temporary Shareholders' Meeting for September 18, 2025, to review the resolutions passed by the board [19][30]. - The meeting will be held both in-person and via online voting, with specific times outlined for participation [31][32]. - The agenda for the meeting includes the resolutions regarding the amendments to the company's internal regulations and the appointment of the new Vice General Manager [35][36].

Core Viewpoint - Strait Holdings (002320) announced the appointment of Ms. Wu Linze as the new Vice General Manager of the company [1] Group 1 - The announcement was made on the evening of September 2 [1]